J Gynecol Oncol.  2015 Jan;26(1):75-76. 10.3802/jgo.2015.26.1.75.

Are we ready for conservative treatment in ovarian cancer?

Affiliations
  • 1Department of Gynecological Oncology, Clinica Universitaria de Navarra School of Medicine, Pamplona, Spain.
  • 2Department of Gynecological Oncology, La Paz University Hospital, Madrid, Spain. ignaciozapardiel@hotmail.com

Abstract

No abstract available.


MeSH Terms

Female
Fertility Preservation/*methods
Humans
Neoplasm Staging
Ovarian Neoplasms/*surgery

Reference

1. Zapardiel I, Diestro MD, Aletti G. Conservative treatment of early stage ovarian cancer: oncological and fertility outcomes. Eur J Surg Oncol. 2014; 40:387–393.
2. Cheng X, Cheng B, Wan X, Lu W, Xie X. Outcomes of conservative surgery in early epithelial ovarian carcinoma. Eur J Gynaecol Oncol. 2012; 33:93–95.
3. Ditto A, Martinelli F, Lorusso D, Haeusler E, Carcangiu M, Raspagliesi F. Fertility sparing surgery in early stage epithelial ovarian cancer. J Gynecol Oncol. 2014; 25:320–327.
4. Kajiyama H. Fertility sparing surgery in patients with early stage epithelial ovarian cancer: implication of survival analysis and lymphadenectomy. J Gynecol Oncol. 2014; 25:270–271.
5. Park JY, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, et al. Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes. Gynecol Oncol. 2008; 110:345–353.
6. Fotopoulou C, Braicu I, Sehouli J. Fertility-sparing surgery in early epithelial ovarian cancer: a viable option? Obstet Gynecol Int. 2012; 2012:238061.
Full Text Links
  • JGO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr